Paraneoplastic Ab

AGNA-1 (Anti-Glial Nuclear Antibody-1) What is AGNA-1? AGNA-1 stands for Anti-Glial Nuclear Antibody-1, an autoantibody that targets proteins found in the nuclei of glial cells—supportive cells in the brain and spinal cord. It is part of a group of paraneoplastic antibodies, which means it can signal that the immune system is reacting to an underlying cancer, especially when there are neurological symptoms. Why is AGNA-1 tested? AGNA-1 is primarily tested when someone has unexplained neurological symptoms that may be due to an autoimmune reaction triggered by cancer. It helps doctors identify a paraneoplastic neurologic syndrome (PNS)—a condition where the immune system attacks the nervous system in response to a tumor elsewhere in the body. What does a positive AGNA-1 result mean? A positive AGNA-1 test is highly associated with small cell lung cancer (SCLC) and may appear before the cancer is diagnosed. It can serve as an important early warning sign for both cancer and neurologic involvement. If you test positive for AGNA-1: Your doctor may recommend further cancer screening (especially of the lungs) Additional neurological tests may be ordered to check for nervous system involvement Early treatment may improve outcomes or prevent worsening symptoms Does a negative result rule out cancer or neurological disease? No. A negative AGNA-1 result does not completely rule out cancer or autoimmune neurological conditions. If symptoms persist, other paraneoplastic or phenotype-specific antibody tests may be needed. Why is AGNA-1 important? AGNA-1 can help connect otherwise unexplained neurological symptoms to a hidden cancer. Detecting it early may lead to faster diagnosis and treatment of both the cancer and the neurological condition.

Amphiphysin Antibody What is the Amphiphysin Antibody? The Amphiphysin antibody is an autoantibody—an immune protein that mistakenly targets the body’s own tissues. Specifically, it targets a protein called amphiphysin, which is involved in nerve cell communication. When this antibody is present, it can interfere with normal nervous system function and may be a sign of an autoimmune neurological disorder, often linked to an underlying cancer. Why is this test important? Testing for the Amphiphysin antibody is typically done when a person is experiencing unexplained neurological symptoms such as muscle stiffness, spasms, difficulty walking, or seizures. These symptoms may be part of a group of disorders known as Paraneoplastic Neurologic Syndromes (PNS)—conditions caused by an immune response to a tumor. This antibody is most often associated with: Stiff-person syndrome Encephalomyelitis (inflammation of the brain and spinal cord) Breast cancer or small cell lung cancer What does a positive result mean? A positive Amphiphysin antibody result suggests that your immune system may be reacting to an underlying tumor by attacking parts of your nervous system. This does not confirm cancer, but it signals that further evaluation is needed. Your healthcare provider may recommend additional tests, such as imaging scans or referrals to specialists in neurology or oncology. What does a negative result mean? A negative result means this specific antibody was not found in your blood. However, it does not rule out other paraneoplastic or autoimmune conditions. If symptoms persist, your doctor may order other related tests. Next steps If you have a positive Amphiphysin antibody result: Your doctor will evaluate your neurological symptoms You may undergo testing to search for hidden (occult) cancers Early diagnosis and treatment can improve outcomes and reduce long-term damage Summary The Amphiphysin antibody is a helpful marker for identifying certain rare autoimmune neurological conditions that may be related to cancer. If detected early, it can guide more targeted investigations and potentially life-saving treatment.

Anti-Hu Antibody (ANNA-1) – What Your Lab Result Means What is Anti-Hu? Anti-Hu antibodies (also called ANNA-1, or anti-neuronal nuclear antibody type 1) are a type of autoantibody—a protein made by your immune system that mistakenly attacks your own body’s cells. Specifically, Anti-Hu targets parts of the nervous system. Its presence in the blood may be a sign of an autoimmune neurological disorder often linked to certain types of cancer. Why Is This Marker Important? Anti-Hu antibodies are commonly associated with paraneoplastic neurologic syndromes (PNS)—a group of rare disorders that occur when the immune system reacts to a hidden (occult) tumor by attacking the nervous system. These antibodies are most often linked to small cell lung cancer, but may also be found in people with other cancers such as prostate, breast, or ovarian cancer. What a Positive Anti-Hu Result May Indicate: An autoimmune attack on the nervous system A potential underlying cancer (especially small cell lung cancer) Neurological symptoms such as: Memory loss Seizures Muscle weakness Numbness or tingling Difficulty walking or speaking What a Negative Result Means: A negative Anti-Hu result means this specific antibody was not found in your blood. However, it does not rule out other autoimmune or cancer-related causes of neurological symptoms. If symptoms persist, your doctor may recommend further testing with other paraneoplastic antibody panels. What to Do Next: If your Anti-Hu result is positive, your healthcare provider may order imaging studies (such as a CT scan or PET scan) and refer you to a neurologist or oncologist. Early detection and treatment of the underlying cause—whether it’s a tumor or an autoimmune disorder—can significantly improve outcomes. In Summary: A positive Anti-Hu antibody test may be an early warning sign of an autoimmune condition affecting the nervous system, often linked to cancer. It’s an important clue that can help guide further evaluation and diagnosis.

Anti-Ri Antibody (Anti-Ri Ab) – What Your Lab Result Means What is Anti-Ri Ab? Anti-Ri antibodies are a type of paraneoplastic antibody, which means they are produced by the immune system in response to abnormal growths like cancer. However, instead of only attacking cancer cells, these antibodies can mistakenly target the nervous system, leading to neurological symptoms. These antibodies are most commonly associated with paraneoplastic neurological syndromes (PNS)—a group of rare but serious disorders that affect the brain, spinal cord, and nerves. Anti-Ri is particularly linked to breast cancer and small cell lung cancer. Why Was This Test Ordered? Your doctor may order the Anti-Ri Ab test if you are experiencing unexplained neurological symptoms, such as: Muscle stiffness or weakness Involuntary eye movements Difficulty with coordination Memory or behavior changes Seizures These symptoms may suggest that your immune system is attacking your nervous system, possibly due to a hidden (occult) cancer. What Does a Positive Anti-Ri Ab Result Mean? A positive Anti-Ri antibody result means that these antibodies are present in your blood. This may indicate: A paraneoplastic neurologic syndrome (PNS) A potential underlying cancer, especially breast or lung cancer The need for further testing (imaging, cancer screening) to look for a tumor However, a positive result doesn’t confirm cancer on its own. It’s part of a bigger diagnostic picture that your healthcare provider will interpret alongside other test results and symptoms. What If the Result Is Negative? A negative result means Anti-Ri antibodies were not found, but this doesn’t rule out all autoimmune or cancer-related conditions. If symptoms continue, your doctor may recommend testing for other related antibodies. Next Steps If your Anti-Ri Ab test is positive, your doctor may suggest: A thorough neurological evaluation Cancer screening (such as MRI, CT scans, or mammograms) Referral to a neurologist or oncologist Bottom Line The Anti-Ri antibody test helps uncover possible links between your immune system, nervous system symptoms, and hidden cancers. Early detection of these antibodies can lead to faster diagnosis and treatment, improving outcomes and quality of life.

Antineuronal Nuclear Antibody Type 3 (ANNA-3) What is Antineuronal Nuclear Antibody Type 3? Antineuronal Nuclear Antibody Type 3 (ANNA-3) is an autoantibody—a type of immune protein that mistakenly targets the body’s own nervous system. Specifically, ANNA-3 targets proteins found in the nuclei of nerve cells. It is classified as a paraneoplastic antibody, meaning it can be associated with an immune response triggered by an underlying cancer. Why is ANNA-3 Important? ANNA-3 is used to help diagnose paraneoplastic neurologic syndromes (PNS)—rare disorders in which the immune system attacks the nervous system in response to a cancer located elsewhere in the body. These neurological symptoms often appear before the cancer is diagnosed, making early detection of ANNA-3 an important clue for doctors. What Does a Positive ANNA-3 Result Mean? A positive ANNA-3 result suggests that the body may be mounting an autoimmune response linked to a hidden (occult) tumor. This antibody has been found in patients with: Lung cancer, especially small cell lung cancer Breast cancer Other solid tumors However, a positive result does not confirm cancer on its own—it simply signals that further testing (such as imaging or cancer screening) may be needed. What Are the Symptoms Linked to ANNA-3? If ANNA-3 is present, a person may experience neurological symptoms such as: Memory loss or confusion (encephalopathy) Seizures Balance or coordination problems (ataxia) Numbness or tingling (neuropathy) Muscle weakness These symptoms result from inflammation or damage to the nervous system caused by the immune response—not the cancer itself. What Does a Negative ANNA-3 Result Mean? A negative ANNA-3 result means this specific antibody was not detected. However, this does not rule out all possible paraneoplastic or autoimmune conditions. If symptoms persist, other antibody tests or imaging studies may still be appropriate. Summary Antineuronal Nuclear Antibody Type 3 (ANNA-3) is a marker that can signal an autoimmune reaction related to a hidden cancer. It is most often used when unexplained neurological symptoms are present. A positive result is a sign that further investigation is needed to rule out or diagnose an underlying malignancy and manage any related nerve damage early. Always consult your doctor or neurologist to interpret your results and decide on the next steps.

The AQP4 Antibody (Cell-based IFA) test detects autoantibodies directed against aquaporin-4, a water channel protein located on astrocytes in the central nervous system. When present, these antibodies cause inflammation and damage, leading to neuromyelitis optica spectrum disorder (NMOSD) — a condition that primarily affects the optic nerves and spinal cord and can mimic multiple sclerosis (MS). The cell-based immunofluorescence assay (IFA) is the most sensitive and specific method for identifying these antibodies.

CASPR2 Antibody, Cell-based IFA What is the CASPR2 Antibody Test? The CASPR2 Antibody, Cell-based IFA test looks for specific autoantibodies that target a protein called CASPR2 (Contactin-associated protein-like 2). This protein is found on nerve cells and plays an important role in how signals are transmitted in the brain and nervous system. The presence of CASPR2 antibodies in the blood can indicate that the immune system is mistakenly attacking the nervous system—often as part of an autoimmune condition. In some cases, these antibodies may also be associated with certain types of cancer. Why is this test done? Doctors may order the CASPR2 antibody test if you are experiencing unexplained neurological symptoms, such as: Memory loss or confusion Seizures Muscle stiffness or spasms Difficulty walking or with coordination Pain, numbness, or weakness This test helps detect autoimmune or paraneoplastic neurological syndromes, which are rare but serious conditions caused by an immune response, sometimes triggered by cancer. What does a positive result mean? A positive CASPR2 antibody result suggests that your symptoms may be related to an autoimmune reaction affecting your nervous system. This can occur with or without an underlying cancer. Conditions linked to CASPR2 antibodies include: Autoimmune encephalitis (inflammation of the brain) Peripheral nerve hyperexcitability (neuromyotonia) Morvan syndrome Rarely, paraneoplastic syndromes associated with tumors (such as thymoma or lung cancer) Your healthcare provider may recommend further tests—such as MRI, lumbar puncture, or cancer screening—to better understand the cause of your symptoms. What does a negative result mean? A negative result means no CASPR2 antibodies were detected. However, it does not completely rule out autoimmune or paraneoplastic conditions. If your symptoms continue, your doctor may consider other antibody tests or additional evaluations. Test Method This test is performed using a cell-based indirect immunofluorescence assay (IFA). It’s a sensitive and specific method that detects antibodies by observing how they bind to CASPR2 proteins on lab-grown cells under a microscope. Takeaway The CASPR2 Antibody test is a valuable tool for identifying autoimmune-related neurological disorders and may provide clues to underlying conditions such as cancer. Early diagnosis and treatment can improve outcomes and help manage symptoms more effectively.

CRMP-5 IgG Antibody What is CRMP-5 IgG? CRMP-5 IgG (also known as anti-CV2) is an autoantibody—an antibody that the immune system makes against the body’s own tissues. It targets a protein called CRMP-5 (Collapsin Response Mediator Protein 5), which is found in the nervous system. The presence of this antibody in the blood or cerebrospinal fluid can be a sign of an immune system reaction often linked to certain types of cancer. Why is CRMP-5 IgG Important? A positive CRMP-5 IgG result may point to a paraneoplastic neurologic syndrome (PNS)—a condition where the immune system reacts to a tumor by mistakenly attacking the nervous system. This antibody can be a clue to an undiagnosed cancer, especially when someone is experiencing unexplained neurological symptoms. CRMP-5 IgG is most commonly associated with: Small cell lung cancer Thymoma (a tumor of the thymus gland) Less commonly, other cancers such as colon, breast, or prostate cancer When is this Test Ordered? Doctors may order the CRMP-5 IgG test if you have: Unexplained neurological symptoms (e.g., memory loss, balance issues, vision problems) Suspected autoimmune disease involving the brain, spinal cord, or nerves A known or suspected cancer, especially if neurological symptoms are present What Does a Positive Result Mean? A positive CRMP-5 IgG result suggests that your immune system may be reacting to a cancer somewhere in the body—even if it hasn’t yet been found. It does not confirm a cancer diagnosis on its own, but it is a strong indicator that further investigation is needed. It may also help explain certain neurologic conditions caused by immune system activity rather than direct tumor growth. What Does a Negative Result Mean? A negative result means this specific antibody was not found. However, it does not rule out all forms of paraneoplastic or autoimmune neurologic disease. If symptoms continue, your doctor may recommend additional testing. Next Steps If CRMP-5 IgG is positive, your healthcare provider may: Order imaging tests to look for a tumor Refer you to a neurologist or oncologist Start treatment to manage immune-related nerve or brain symptoms Summary CRMP-5 IgG is an important biomarker that can help detect an autoimmune reaction linked to certain cancers. While it doesn’t confirm a diagnosis by itself, it provides valuable information that can guide further testing and treatment. Always talk with your healthcare provider to understand what your test results mean for your specific health situation.

The DPPX antibody test checks for autoantibodies against DPPX (DPP6), a neuronal cell-surface protein that helps regulate brain and nerve excitability. When present, these antibodies are linked to autoimmune DPPX encephalitis, a potentially treatable cause of symptoms like memory/behavior changes, agitation, tremor/myoclonus, sleep disturbance, seizures, and often prominent gastrointestinal symptoms (weight loss, diarrhea).

LGI1 Antibody, Cell-based IFA What is the LGI1 Antibody Test? The LGI1 Antibody, Cell-based IFA test is used to detect antibodies against the Leucine-Rich Glioma-Inactivated 1 (LGI1) protein. This test helps identify certain autoimmune neurological conditions, including a rare type of autoimmune encephalitis, which is a brain inflammation caused by the immune system mistakenly attacking healthy brain cells. Why is this Test Important? The presence of LGI1 antibodies in the blood can indicate LGI1 autoimmune encephalitis, a condition that can cause memory loss, confusion, seizures, and abnormal movements. This disorder is often not caused by an infection or cancer, but rather by the body’s immune system attacking its own brain tissue. Early detection is critical. When caught early, many patients respond well to immune-modulating treatments, and symptoms can significantly improve or even fully resolve. Conditions Linked to LGI1 Antibodies Autoimmune limbic encephalitis (affecting memory and behavior) Focal seizures, often involving facial or arm movements Hyponatremia (low sodium levels in the blood), which can worsen confusion or fatigue Unlike some other autoimmune brain conditions, LGI1 antibody-associated encephalitis is less commonly linked to cancer, making it a non-paraneoplastic form of encephalitis. How is the Test Performed? This test uses a cell-based indirect immunofluorescence assay (IFA) to detect LGI1 antibodies in a blood sample. The cell-based IFA method is highly specific and helps reduce the chance of false positives. What Do the Results Mean? Positive LGI1 antibodies suggest that your immune system is targeting the LGI1 protein, which may be causing neurological symptoms. This result supports a diagnosis of autoimmune encephalitis and may prompt treatment with immunotherapy. Negative results mean LGI1 antibodies were not detected, but this does not fully rule out autoimmune brain conditions. Your doctor may order other tests if symptoms continue. What Should I Do Next? If your test is positive, your healthcare provider may recommend: MRI or EEG to look for brain inflammation or abnormal electrical activity Immunotherapy (like steroids or IVIG) Follow-up with a neurologist who specializes in autoimmune or inflammatory brain diseases Summary The LGI1 Antibody, Cell-based IFA test plays a vital role in diagnosing a treatable form of autoimmune encephalitis. If you’re experiencing unexplained memory loss, seizures, or behavioral changes, this test can help uncover an immune-related cause—and guide you to the right treatment path.

Paraneoplastic Antibodies (Paraneoplastic Ab) Paraneoplastic antibodies are autoantibodies produced by the immune system in response to a tumor elsewhere in the body. Instead of targeting the tumor directly, these antibodies mistakenly attack the nervous system, leading to a group of disorders known as Paraneoplastic Neurologic Syndromes (PNS). These antibodies are important biomarkers that can help detect hidden (occult) cancers and explain unexplained neurological symptoms. Clinical Relevance: The presence of paraneoplastic antibodies may indicate an autoimmune neurological condition triggered by an underlying malignancy. These markers can assist in diagnosing neurological symptoms such as: Encephalopathy Seizures Myelopathy Sensory neuropathy Cerebellar degeneration Stiff-person syndrome Commonly Tested Antibodies Include: Anti-Hu (ANNA-1) – linked to small cell lung cancer Anti-Yo (PCA-1) – associated with breast and gynecologic cancers Anti-Ri (ANNA-2) – seen in breast and lung cancer CRMP-5 (CV2), Ma2, Amphiphysin, and others Interpretation Notes: A positive result supports a potential diagnosis of PNS and may suggest an underlying cancer, prompting further diagnostic imaging and oncology evaluation. A negative result does not rule out all clinically relevant antibodies. If symptoms persist, phenotype-specific antibody panels (e.g., for encephalopathy, dementia, or neuropathy) should be considered. Why It Matters: Early detection of paraneoplastic antibodies can lead to earlier diagnosis and treatment of cancer and may prevent or reduce irreversible neurological damage.

PCA Type-1 (Anti-Yo) Antibody What is PCA Type-1 (Anti-Yo)? PCA Type-1, also known as Anti-Yo antibody, is an autoantibody—an immune protein that mistakenly targets your own tissues. In this case, it targets nerve cells in the brain and spinal cord. The presence of Anti-Yo is often linked to paraneoplastic neurologic syndromes (PNS), which are rare autoimmune conditions triggered by certain types of cancer. Why is this test important? This test helps detect whether your immune system is producing Anti-Yo antibodies. A positive result can be an important clue in diagnosing neurological symptoms that may be related to an underlying, and sometimes hidden, cancer—especially breast cancer or gynecologic cancers (like ovarian or uterine cancer). What does a positive Anti-Yo result mean? If Anti-Yo antibodies are found in your blood, it suggests your immune system may be reacting to a tumor. This can lead to a condition called paraneoplastic cerebellar degeneration, which affects coordination and balance. Symptoms might include: Trouble walking or balancing Slurred speech Dizziness or tremors Unexplained neurological changes A positive result doesn’t confirm a cancer diagnosis on its own, but it’s a strong signal that further evaluation is needed, including cancer screening and neurological assessment. What does a negative result mean? A negative Anti-Yo result means these specific antibodies were not found in your blood. However, this does not rule out all paraneoplastic or autoimmune conditions. If symptoms persist, your doctor may recommend testing for other antibodies based on your clinical presentation. When is this test ordered? Your healthcare provider might order this test if you are experiencing: Unexplained neurological symptoms Rapidly progressing balance or coordination problems Symptoms suggestive of an autoimmune or paraneoplastic condition If there’s a history or suspicion of breast or gynecologic cancer What happens next? If your test is positive, your care team may recommend: Imaging (like MRI or CT scans) to look for tumors A referral to a neurologist or oncologist Additional antibody testing based on your symptoms Summary The PCA Type-1 (Anti-Yo) Antibody test is a valuable tool for uncovering autoimmune neurological disorders and hidden cancers, especially in women with unexplained brain or movement symptoms. Early detection can lead to more effective treatment and better outcomes.

Purkinje Cell Cytoplasmic Antibody Type 2 (PCA-2) What is PCA-2? Purkinje Cell Cytoplasmic Antibody Type 2 (PCA-2) is a type of paraneoplastic antibody, which means it is made by the immune system in response to a tumor. However, instead of attacking the cancer directly, the immune system mistakenly targets healthy nerve cells in the brain—specifically, the Purkinje cells found in the cerebellum, the part of the brain responsible for coordination and balance. Why is PCA-2 tested? PCA-2 is typically tested when a person is experiencing unexplained neurological symptoms, especially if doctors suspect a paraneoplastic neurologic syndrome (PNS). These symptoms may include: Balance or coordination problems (ataxia) Muscle stiffness or spasms Memory or cognitive changes Sensory issues or numbness A positive PCA-2 test can provide a clue that these symptoms may be caused by an autoimmune response related to an underlying cancer. What does a positive PCA-2 result mean? A positive PCA-2 result suggests the presence of a paraneoplastic syndrome and may be associated with an undiagnosed tumor, most often: Small cell lung cancer (SCLC) Other neuroendocrine or lung-related tumors It does not confirm a cancer diagnosis, but it serves as a red flag for doctors to investigate further, often with imaging studies like a CT scan or PET scan. What does a negative result mean? A negative PCA-2 test means this specific antibody was not detected in your blood. However, this does not rule out all autoimmune or paraneoplastic causes. If symptoms continue, your doctor may recommend additional testing for other antibodies or perform a phenotype-specific paraneoplastic panel. Why it matters Identifying PCA-2 early can help doctors: Diagnose rare autoimmune brain conditions sooner Detect hidden cancers at an earlier stage Prevent further neurological damage through appropriate treatment

Purkinje Cell Cytoplasmic Antibody Type Tr (PCA-Tr) What is PCA-Tr? Purkinje Cell Cytoplasmic Antibody Type Tr (PCA-Tr) is an autoantibody—a type of protein made by your immune system that mistakenly targets your own tissues. Specifically, PCA-Tr targets Purkinje cells, which are specialized neurons found in the cerebellum, the part of the brain that helps control coordination and balance. This antibody is classified as a paraneoplastic antibody, meaning it is often produced as a response to an underlying cancer. The immune system, while trying to fight the cancer, may also attack healthy brain tissue—leading to neurological symptoms. What does a positive PCA-Tr result mean? A positive PCA-Tr test is a strong indicator of a paraneoplastic neurological syndrome (PNS)—a rare group of disorders that occur when cancer-fighting antibodies mistakenly damage parts of the nervous system. PCA-Tr is most commonly associated with: Hodgkin lymphoma, a type of blood cancer In many cases, PCA-Tr is linked to a condition called paraneoplastic cerebellar degeneration (PCD), where the cerebellum becomes inflamed and damaged, leading to symptoms like: Unsteady gait or trouble walking Dizziness or vertigo Slurred speech Coordination problems Double vision or abnormal eye movements Why is this test important? If you're experiencing unexplained balance issues or neurological symptoms—and especially if there's suspicion of an underlying cancer—testing for PCA-Tr can help identify whether your immune system is involved. A positive result often prompts doctors to search for an occult (hidden) cancer, particularly Hodgkin lymphoma. Early detection can lead to quicker treatment of both the neurological symptoms and any associated cancer. Does a negative result rule out all problems? No. A negative PCA-Tr result does not rule out all paraneoplastic or autoimmune neurological conditions. If symptoms persist, your doctor may recommend testing for other antibodies or ordering brain imaging. Summary PCA-Tr is an autoantibody linked to brain inflammation caused by the immune response to cancer. It is most often associated with Hodgkin lymphoma and paraneoplastic cerebellar degeneration. A positive result can guide doctors toward further testing for underlying cancer and immune-based treatments. Always consult your healthcare provider for interpretation of test results and next steps tailored to your specific condition.

VGCC Antibody (Voltage-Gated Calcium Channel Antibody) What is the VGCC Antibody? The VGCC (Voltage-Gated Calcium Channel) antibody is an autoantibody that targets calcium channels found on the surface of nerve cells. These channels play a critical role in transmitting nerve signals, especially in muscles and the brain. When the immune system mistakenly produces VGCC antibodies, it can interfere with normal nerve function and may be linked to certain neurological and autoimmune disorders. Why is this test important? Testing for VGCC antibodies helps doctors understand whether an autoimmune process is affecting the nervous system. In some cases, these antibodies are associated with a group of conditions called paraneoplastic neurological syndromes (PNS)—autoimmune disorders triggered by an underlying cancer. They can also be present in non-cancer-related autoimmune conditions. Conditions associated with VGCC antibodies Lambert-Eaton Myasthenic Syndrome (LEMS): A rare condition that causes muscle weakness, often linked to small cell lung cancer. VGCC antibodies are found in most cases. Paraneoplastic Cerebellar Degeneration (PCD): A condition that affects balance and coordination due to an autoimmune attack on the cerebellum. Autoimmune encephalitis or neuropathy: In some cases, VGCC antibodies are found without any underlying cancer, especially when there is inflammation in the brain or peripheral nerves. What does an elevated VGCC antibody result mean? An elevated result means VGCC antibodies are present in the blood. This may suggest: An autoimmune neurological disorder like LEMS A potential underlying tumor (often small cell lung cancer) The need for further testing, such as imaging or additional antibody panels However, an elevated result does not confirm cancer. It simply raises the suspicion and helps guide further investigation. What does a normal result mean? A normal VGCC antibody test suggests that these specific autoantibodies were not found. However, it does not rule out all autoimmune neurological conditions. Depending on your symptoms, your doctor may recommend other tests. In summary The VGCC antibody test helps identify autoimmune activity affecting the nervous system, and may serve as a clue to deeper conditions, including hidden cancers. If you have unexplained muscle weakness, coordination problems, or other neurological symptoms, this test can be an important step in finding answers.